Oxford Nanopore Technologies PLC at Barclays Global Healthcare Conference Transcript
Good afternoon, everyone. My name is John Unwin, I'm one of the analysts on the European med tech and services team at Barclays. And I'm delighted to be joined by Nick Keher today, Chief Financial Officer of Oxford Nanopore Technologies. Welcome Nick. Thank you for coming.
Thank you, Jonathon, for having me.
Lots of opportunities throughout ponanopor. We'll dive into lots of them as well. You split your revenues into sort of four end markets, research, clinical, biopharma and applied industrial Today, research is the biggest portion of your revenues, but it's not the fastest growing. I wonder if you could talk a little bit about your journey into the clinical and biopharma space, perhaps setting out the move from research to sort of LDTs to regulated test, sort of where we are on that journey today, we've spoken
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
